PCM
EW icon

Polymer Capital Management’s Edwards Lifesciences EW Stock Holding History

Polymer Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
+4,847
New +$406K 0.06% 435
2026
Q1 		– Sell
-4,462
Closed -$380K – 891
2025
Q4 		$380K Sell
4,462
-5,232
-54% -$429K 0.04% 541
2025
Q3 		$754K Buy
+9,694
New +$757K 0.08% 292

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Polymer Capital Management's EW Position: Q2 2026 in Review

Polymer Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 4,847 shares worth $438K. The stake represents 0.06% of the portfolio and ranks #435 among its holdings. This is a return to the name: Polymer Capital Management previously reported a position in EW as recently as Q4 2025.

Polymer Capital Management first reported a position in EW in Q3 2025 and has held it in 3 quarters since. The position peaked at $754K in Q3 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Polymer Capital Management held 4,847 shares of Edwards Lifesciences worth $438K as of Q2 2026.
  • Edwards Lifesciences was a new Polymer Capital Management position in Q2 2026.
  • Edwards Lifesciences made up 0.06% of Polymer Capital Management's portfolio in Q2 2026, its #435 holding.
  • Polymer Capital Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 3 quarters since.
  • Polymer Capital Management's Edwards Lifesciences position peaked at $754K in Q3 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.